'Extraordinary' Blue Cross Deal Includes $2.8B Payout

By Bryan Koenig · October 15, 2024, 6:54 PM EDT

The Blue Cross Blue Shield network will shell out $2.8 billion and invest "hundreds of millions" more overhauling its claims systems to soften barriers between members, in a massive antitrust settlement...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

In Re Blue Cross Blue Shield Antitrust Litigation MDL 2406

Case Number

Court

Alabama Northern

Nature of Suit

890 Other Statutory Actions

Date Filed

January 08, 2013

Recent Articles By Bryan

October 16, 2024
Caremark, Optum Say FTC Insulin Case Gets PBMs All Wrong
October 07, 2024
Merck Immune For 'Inflated' Vax Claims To FDA, 3rd Circ. Says
September 06, 2024
Actelion Must Face Tracleer Antitrust Suit With Class Certified
August 28, 2024
Jazz, Hikma Must Face Bulk Of Xyrem Antitrust Suit
August 14, 2024
Nursing Co. Exec Can't Split Up Fraud, Wage-Fixing Charges
August 12, 2024
9th Circ. Won't Rethink Upending Sutter Health Antitrust Win
July 31, 2024
Inhaler Patents 'Must Be' In Orange Book, Teva Tells Fed. Circ.
July 17, 2024
Heart Doctor's Sham Suit Claims Cut From Antitrust Row
July 11, 2024
Fed. Circ. Pauses Ouster Of Teva Patents From Orange Book
July 08, 2024
Texas Anesthesia Co. Can't Pause Or Appeal Suit, FTC Says